levodopa has been researched along with Weight Loss in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 9 (47.37) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Antonini, A; Biundo, R; Calandrella, D; Carecchio, M; Carrer, T; Del Sorbo, F; Farinati, F; Garrì, F; Mainardi, M; Pezzoli, G; Pistonesi, F; Russo, FP; Sandre, M; Savarino, E; Soliveri, P; Weis, L; Zecchinelli, AL | 1 |
Artaud, F; Corvol, JC; Elbaz, A; Lee, PC; Mangone, G; Vidailhet, M | 1 |
Eerola-Rautio, J; Kenttämies, A; Kylänpää, L; Lindström, O; Lyytinen, J; Pekkonen, E; Udd, M | 1 |
Benesh, J; Boyd, JT; Chatamra, K; Eaton, S; Espay, AJ; Facheris, MF; Fernandez, HH; Fung, VSC; Hall, C; Lew, MF; Robieson, WZ; Rodriguez, RL; Slevin, JT; Standaert, DG; Vanagunas, AD; Zadikoff, C | 1 |
Beccaria, L; Fabbri, M; Ferreira, JJ; Lopiano, L; Merola, A; Montanaro, E; Palermo, S; Romagnolo, A; Zibetti, M | 1 |
Ehlen, F; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T; Taskin, B | 1 |
Sharma, JC; Vassallo, M | 1 |
Avolio, C; De Francesco, V; Lalla, A; Martino, T; Melchionda, D; Specchio, LM; Tonti, P | 1 |
Granérus, AK; Lorefält, B; Toss, G | 1 |
Bachmann, CG; Brunner, E; Trenkwalder, C; Zapf, A | 1 |
Hazan, D; Siegert, S; Szyper-Kravitz, M | 1 |
Barichella, M; Cancello, R; Cassani, E; Faillace, G; Moise, G; Pezzoli, G; Privitera, G; Zecchinelli, A; Zulian, A | 1 |
Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C | 1 |
Borowik, H; Drozdowski, W; Kułakowska, A; Pogorzelski, R | 1 |
Carlsson, M; Ganowiak, W; Granérus, AK; Lorefält, B; Pålhagen, S; Toss, G; Unosson, M | 1 |
Hasoon, M; Macnamara, L; Ross, I; Sharma, JC; Vassallo, M | 1 |
Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
Inoue, S; Nakamura, S; Numata, K; Okazaki, H; Takamura, Y; Tanaka, K | 1 |
1 review(s) available for levodopa and Weight Loss
Article | Year |
---|---|
Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype.
Topics: Antiparkinson Agents; Body Weight; Dyskinesia, Drug-Induced; Energy Intake; Female; Humans; Levodopa; Male; Nutritional Status; Parkinson Disease; Quality of Life; Sex Factors; Smell; Thinness; Treatment Outcome; Weight Loss | 2014 |
3 trial(s) available for levodopa and Weight Loss
Article | Year |
---|---|
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Double-Blind Method; Drug Combinations; Female; Gels; Humans; International Cooperation; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Polyneuropathies; Weight Loss | 2018 |
A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
Topics: Aged; Aged, 80 and over; Anorexia; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Vomiting; Weight Loss | 2005 |
Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Logistic Models; Male; Parkinson Disease; Retrospective Studies; Risk Factors; Sex Factors; Weight Loss | 2006 |
15 other study(ies) available for levodopa and Weight Loss
Article | Year |
---|---|
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Retrospective Studies; Weight Loss | 2022 |
Longitudinal association between dopamine agonists and weight in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Body Mass Index; Compulsive Behavior; Dopamine Agonists; Feeding and Eating Disorders; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Weight Gain; Weight Loss | 2020 |
Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome; Weight Loss | 2017 |
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Weight Loss | 2019 |
Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Female; Gels; Humans; Infusions, Parenteral; Intestines; Levodopa; Male; Middle Aged; Patient Outcome Assessment; Polyneuropathies; Prospective Studies; Weight Loss | 2013 |
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Ulcer; Duodenum; Dyskinesias; Endoscopes, Gastrointestinal; Humans; Levodopa; Male; Parkinson Disease; Tomography, X-Ray Computed; Weight Loss | 2016 |
Weight loss, body fat mass, and leptin in Parkinson's disease.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Leptin; Levodopa; Male; Middle Aged; Parkinson Disease; Radioimmunoassay; Sex Factors; Statistics, Nonparametric; Weight Loss | 2009 |
Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
Topics: Age of Onset; Aged; Antiparkinson Agents; Body Mass Index; Body Weight; Dopamine Agents; Dyskinesias; Eating; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Severity of Illness Index; Time Factors; Weight Loss | 2009 |
Severe weight loss in a young Parkinson's disease patient: a multidisciplinary approach to diagnosis and treatment.
Topics: Antiparkinson Agents; Carbidopa; Caregivers; Disease Progression; Domestic Violence; Drug Combinations; Eating; Female; Humans; Hypertrichosis; Levodopa; Middle Aged; Nutritional Status; Parkinson Disease; Weight Loss | 2011 |
The sleeve gastrectomy intervention to treat morbid obesity in a Parkinson's disease patient.
Topics: Bariatric Surgery; Body Mass Index; Female; Gastrectomy; Humans; Levodopa; Middle Aged; Obesity, Morbid; Parkinson Disease; Treatment Outcome; Weight Loss | 2013 |
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss | 2013 |
[Wearing off phenomenon presenting with features of paroxysmal abdominal pain].
Topics: Abdominal Pain; Aged; Antiparkinson Agents; Female; Gastrointestinal Motility; Humans; Levodopa; Parkinson Disease; Wasting Syndrome; Weight Loss | 2003 |
Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Deglutition Disorders; Female; Follow-Up Studies; Humans; Levodopa; Male; Motor Activity; Movement Disorders; Nausea; Parkinson Disease; Smell; Weight Loss | 2005 |
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss | 1992 |
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Topics: Adolescent; Adult; Arginine; Body Weight; Diet, Reducing; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Obesity; Weight Loss | 1990 |